Year-over-year, this metric declined by 100.0%, from $1.00K to $0.00. Over 2 years (FY 2021 to FY 2023), Total Cost of Revenue shows a downward trend with a -100.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.11M | $2.10M | $3.45M | $1.99M | $2.20M | $2.53M | $1.00K | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | +89.1% | +64.1% | -42.5% | +10.9% | +14.7% | -100.0% | -100.0% | — | — | — |
| YoY Change | — | — | — | — | +98.0% | +20.1% | -100.0% | -100.0% | -100.0% | -100.0% | -100.0% |